Skip to content

    Jyothy Labs

    JYOTHYLAB
    Fast Moving Consumer Goods·3 Feb 2025
    Management Summary

    Jyothy Labs reported a mixed Q3 FY25, with strong volume growth of 8% but lower value growth of 4% due to promotional activities and higher grammages. While gross margins were protected, EBITDA margins saw a 110 bps decline. The company is focusing on diversifying away from the struggling HI segment and expanding other categories, despite a challenging demand environment and competitive pressures. The outlook for Q4 FY25 remains tough.

    Highlights

    5
    • Consolidated revenues from operations reached INR704 crores.

    • Volume growth was strong at 8% year-on-year.

    • Gross margin was protected at 49.8% year-on-year.

    • Ex-HI segment volume grew by 10.3% year-on-year.

    • Profit after tax for the 9-month period improved to INR941.1 crores from INR291.2 crores last year.

    Concerns

    5
    • Value growth of 4% was lower than volume growth of 8% due to higher grammages and promotional prices.

    • Operating EBITDA margin declined by 110 bps to 16.4% from 17.5% last year.

    • Personal Care segment declined by 3.7% year-on-year in Q3.

    • Home insecticide (HI) segment witnessed a 7.3% degrowth for the 9-month period.

    • Q4 outlook is challenging, with initial signs not encouraging for volume growth.

    Key financials

    Metrics

    11

    Periods

    2

    Headline

    5
    • Consolidated Revenue
      ₹704 Cr
      YoY+4%
    • Volume Growth
      YoY+8%
    • Gross Margin
      49.8%
      YoY0%
    • Operating EBITDA Margin
      16.4%
      YoY-1.1%
    • Operating Expenses Growth
      YoY+7.5%

    9M

    6
    • Value Growth
      YoY+4%
    • Volume Growth
      YoY+7.2%
    • Gross Margin
      50.4%
      YoY+1.5%
    • EBITDA
      ₹387.7 Cr
      YoY+4.4%
    • EBITDA Margin
      17.8%
      YoY+0.1%

    Segment breakdown

    Ex-HI Segment
    Value Growth Volume Growth
    Fabric Care
    Growth
    Dishwash
    Growth14.1% Exo Market Share
    Personal Care
    Decline
    Home Insecticide (HI)
    9M Degrowth4.5% Contribution to Revenue
    Ujala IDD Detergent Powder (Kerala)
    24.5% Market Share
    Rest of Category (excluding HI)
    Volume Growth
    List

    Guidance & targets

    3
    CategoryTargetPriority
    Margin
    Operating EBITDA Margin
    16% to 17%
    Medium
    Volume-Value Gap
    Volume-Value Growth Gap
    2% to 3%
    High
    Volume
    Q4 FY25 Volume Growth Outlook
    not meaningfully different or superior
    High

    Q4 FY25 Volume Growth

    Next quarter (Q4 FY25 results)
    CurrentQ3 FY25 volume growth 8%, but Q4 outlook 'challenging'
    TargetImprovement over Q3, or at least not a further decline

    Why it matters

    Management indicated a tough Q4, so verifying actual volume performance will be key to understanding demand recovery.

    No, it looks challenging. The initial signs in quarter 4 are not very encouraging. So I don't think quarter 4 is going to be meaningfully different or superior. So it's going to be tough.

    How to verify

    key_financials.metrics[label='Volume Growth']

    Risks & concerns

    4
    RiskSeverity

    Subdued Demand Environment

    The overall demand environment continues to be subdued amid inflationary pressures and muted growth rates in urban India.Management acknowledged

    high

    Input Price Volatility

    Input prices are fluctuating, crude prices are fluctuating, creating a highly volatile scenario.Management acknowledged

    medium

    Intense Competition

    The market scenario is very, very competitive and the external environment is not very conducive.Management acknowledged

    medium

    Challenging Q4 FY25 Outlook

    Initial signs in Q4 are not very encouraging, and the quarter is expected to be tough with no meaningful difference or superiority.Management acknowledged

    high

    Q&A highlights

    7

    “While the market conditions have been bad, we trust our formulation very well. And it's what do you say. It's a very solid formulation. And now only we are in this space, and I have a lot of confidence in our formulation. It's the coil segment that has degrown for us. If you see year-on-year, we are at good double-digit growth in the Liquids segment.”

    Analyst questioned the company's competitive position and sharper decline in HI despite a new technology from a market leader, prompting management to defend its formulation and highlight growth in the liquids segment of HI.

    asked by Abneesh Roy

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 FY25 Performance Overview

    Jyothy Labs reported consolidated revenues of INR704 crores for Q3 FY25, reflecting a 4% year-on-year value growth and a robust 8% volume growth. Despite this, the gross margin was maintained at 49.8% year-on-year. However, the operating EBITDA margin saw a decline of 110 bps, settling at 16.4% compared to 17.5% in the previous year, primarily due to higher operating expenses growing 7-8% and the disparity between value and volume growth.

    02

    9-Month Financial Performance and Profitability

    For the nine months ended December 31, 2024, the company achieved a 4% value growth and 7.2% volume growth. Gross margin improved by 150 bps to 50.4% from 48.9% last year. Absolute EBITDA increased to INR387.7 crores from INR371.4 crores, with the EBITDA margin slightly improving by 10 bps to 17.8%. Notably, Profit After Tax for this period significantly rose to INR941.1 crores from INR291.2 crores in the prior year.

    03

    Segmental Performance and Strategic Shifts

    The Ex-HI segment demonstrated strong performance with 6.1% year-on-year value growth and 10.3% volume growth in Q3. Fabric Care achieved nearly double-digit growth, and the Dishwash segment grew by 3.6%. However, the Personal Care segment declined by 3.7%, and the Home Insecticide (HI) segment experienced a 7.3% degrowth for the 9-month period. The company is actively reducing its dependence on the HI segment, which now contributes 4-5% of revenue, down from 15% historically, focusing on growing other categories.

    04

    Demand Environment and Consumer Behavior

    The demand environment remains subdued, characterized by inflationary pressures and muted growth in urban India, although rural demand saw a decent recovery due to good monsoon and growing wages. Management noted a trend of consumer down-trading and an increase in unplanned, low-to-moderate order value purchases, influenced by the rapid rise of quick commerce platforms promising 10-30 minute deliveries in urban markets.

    05

    New Product Launches and Innovation Pipeline

    Jyothy Labs launched several new products, including Jovia beauty soap in the mass segment, Mr. White Liquid Detergent in strategic markets, and the Maxo anti-mosquito racket. These launches are part of a broader strategy to explore new segments, enhance the product portfolio, and drive future growth, with a focus on innovation and leveraging digital platforms for targeted consumer engagement.

    06

    Q4 FY25 Outlook and Margin Management

    Management expressed a challenging outlook for Q4 FY25, with initial signs not being very encouraging for volume growth, suggesting the quarter may not be meaningfully different or superior. While the company aims to maintain an EBITDA margin of 16-17% for the next financial year, they acknowledged the highly volatile input prices and competitive market scenario, emphasizing efforts to protect Q4 margins. Price increases in the body soap category in Q3 are expected to be visible in Q4.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.